APBN
MCID: PLY158
MIFTS: 31

Polyglucosan Body Neuropathy, Adult Form (APBN)

Categories: Genetic diseases, Liver diseases, Metabolic diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Polyglucosan Body Neuropathy, Adult Form

MalaCards integrated aliases for Polyglucosan Body Neuropathy, Adult Form:

Name: Polyglucosan Body Neuropathy, Adult Form 58 76
Polyglucosan Body Disease, Adult Form 58 76 13 74
Apbd 58 60 76
Adult Polyglucosan Body Disease 60 76
Apbn 58 76
Polyglucosan Body Disease, Adult Form; Apbd 58

Characteristics:

Orphanet epidemiological data:

60
adult polyglucosan body disease
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Adult; Age of death: elderly;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
slowly progressive
onset after age 40 years
loss of ambulation in mid-sixties
high frequency among individuals of ashkenazi jewish descent


HPO:

33
polyglucosan body neuropathy, adult form:
Onset and clinical course adult onset slow progression
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 58 263570
MeSH 45 D009422
ICD10 via Orphanet 35 E74.0
UMLS via Orphanet 75 C1849722
Orphanet 60 ORPHA206583
MedGen 43 C1849722
UMLS 74 C1849722

Summaries for Polyglucosan Body Neuropathy, Adult Form

OMIM : 58 Adult polyglucosan body neuropathy is a late-onset, slowly progressive disorder affecting the central and peripheral nervous systems. Patients typically present after age 40 years with a variable combination of cognitive impairment, pyramidal tetraparesis, peripheral neuropathy, and neurogenic bladder. Other manifestations include cerebellar dysfunction and extrapyramidal signs. The pathologic hallmark of the disorder is the widespread accumulation of round, intracellular polyglucosan bodies throughout the nervous system, which are confined to neuronal and astrocytic processes (summary by Lossos et al., 1998). (263570)

MalaCards based summary : Polyglucosan Body Neuropathy, Adult Form, also known as polyglucosan body disease, adult form, is related to adult polyglucosan body disease and dementia, and has symptoms including difficulty passing urine and upper motor neuron signs. An important gene associated with Polyglucosan Body Neuropathy, Adult Form is GBE1 (1,4-Alpha-Glucan Branching Enzyme 1). Affiliated tissues include spinal cord, skin and brain, and related phenotypes are orthostatic hypotension and gait disturbance

UniProtKB/Swiss-Prot : 76 Polyglucosan body neuropathy, adult form: A late-onset, slowly progressive disorder affecting the central and peripheral nervous systems. Patients typically present after age 40 years with a variable combination of cognitive impairment, pyramidal tetraparesis, peripheral neuropathy, and neurogenic bladder. Other manifestations include cerebellar dysfunction and extrapyramidal signs. The pathologic hallmark of APBN is the widespread accumulation of round, intracellular polyglucosan bodies throughout the nervous system, which are confined to neuronal and astrocytic processes.

Related Diseases for Polyglucosan Body Neuropathy, Adult Form

Diseases related to Polyglucosan Body Neuropathy, Adult Form via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 adult polyglucosan body disease 11.6
2 dementia 10.4
3 frontotemporal dementia 10.2
4 glycogen storage disease 10.0
5 liver disease 10.0
6 plexopathy 10.0
7 tremor 10.0

Graphical network of the top 20 diseases related to Polyglucosan Body Neuropathy, Adult Form:



Diseases related to Polyglucosan Body Neuropathy, Adult Form

Symptoms & Phenotypes for Polyglucosan Body Neuropathy, Adult Form

Human phenotypes related to Polyglucosan Body Neuropathy, Adult Form:

33 60 (show all 27)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 orthostatic hypotension 33 occasional (7.5%) HP:0001278
2 gait disturbance 60 33 Very frequent (99-80%) HP:0001288
3 neurogenic bladder 60 33 Very frequent (99-80%) HP:0000011
4 distal sensory impairment 60 33 Frequent (79-30%) HP:0002936
5 intellectual disability 60 Very frequent (99-80%)
6 ataxia 60 Occasional (29-5%)
7 spasticity 60 Very frequent (99-80%)
8 muscle weakness 60 Very frequent (99-80%)
9 abnormal pyramidal sign 60 Very frequent (99-80%)
10 behavioral abnormality 60 Frequent (79-30%)
11 cognitive impairment 33 HP:0100543
12 abnormality of metabolism/homeostasis 33 HP:0001939
13 emg abnormality 60 Occasional (29-5%)
14 peripheral neuropathy 60 Very frequent (99-80%)
15 limitation of joint mobility 60 Occasional (29-5%)
16 urinary bladder sphincter dysfunction 60 Very frequent (99-80%)
17 skin ulcer 60 Frequent (79-30%)
18 paresthesia 33 HP:0003401
19 dementia 60 Occasional (29-5%)
20 abnormality of extrapyramidal motor function 60 Occasional (29-5%)
21 spastic paraplegia 33 HP:0001258
22 urinary incontinence 60 Very frequent (99-80%)
23 peripheral axonal neuropathy 33 HP:0003477
24 hemiparesis 60 Very frequent (99-80%)
25 tetraparesis 33 HP:0002273
26 abnormal upper motor neuron morphology 33 HP:0002127
27 abnormality of the cerebral white matter 33 HP:0002500

Symptoms via clinical synopsis from OMIM:

58
Neurologic Central Nervous System:
gait disturbance
cognitive impairment
spastic paraplegia
neurogenic bladder
upper motor neuron signs
more
Genitourinary Bladder:
neurogenic bladder
micturition difficulties

Cardiovascular Vascular:
orthostatic hypotension (in some patients)

Neurologic Peripheral Nervous System:
peripheral axonal neuropathy
distal sensory impairment
paresthesias

Head And Neck Eyes:
saccadic movements (in some patients)

Laboratory Abnormalities:
decreased or absent glycogen branching enzyme activity

Clinical features from OMIM:

263570

UMLS symptoms related to Polyglucosan Body Neuropathy, Adult Form:


difficulty passing urine, upper motor neuron signs

Drugs & Therapeutics for Polyglucosan Body Neuropathy, Adult Form

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease Completed NCT00947960 Phase 2 Triheptanoin

Search NIH Clinical Center for Polyglucosan Body Neuropathy, Adult Form

Genetic Tests for Polyglucosan Body Neuropathy, Adult Form

Anatomical Context for Polyglucosan Body Neuropathy, Adult Form

MalaCards organs/tissues related to Polyglucosan Body Neuropathy, Adult Form:

42
Spinal Cord, Skin, Brain

Publications for Polyglucosan Body Neuropathy, Adult Form

Articles related to Polyglucosan Body Neuropathy, Adult Form:

(show all 49)
# Title Authors Year
1
A double-blind, placebo-controlled trial of triheptanoin in adult polyglucosan body disease and open-label, long-term outcome. ( 29110179 )
2018
2
Guaiacol as a drug candidate for treating adult polyglucosan body disease. ( 30185673 )
2018
3
Novel GBE1 mutation in a Japanese family with adult polyglucosan body disease. ( 28265589 )
2017
4
Teaching NeuroImages: Prominent spinal cord atrophy and white matter changes in adult polyglucosan body disease. ( 28507268 )
2017
5
A novel image-based high-throughput screening assay discovers therapeutic candidates for adult polyglucosan body disease. ( 28827282 )
2017
6
Polyglucosan bodies in intramuscular nerve branches are a poor predictor of GBE1 mutation and adult polyglucosan body disease. ( 26670585 )
2016
7
Adult polyglucosan body disease presenting as a unilateral progressive plexopathy. ( 26789422 )
2016
8
A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body disease. ( 25544507 )
2015
9
Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease. ( 25665141 )
2015
10
Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian family. ( 25728520 )
2015
11
Frequent misdiagnosis of adult polyglucosan body disease. ( 26194201 )
2015
12
Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease. ( 24380807 )
2014
13
Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration. ( 24750115 )
2014
14
Coexisting adult polyglucosan body disease with frontotemporal lobar degeneration with transactivation response DNA-binding protein-43 (TDP-43)-positive neuronal inclusions. ( 22506890 )
2013
15
Acute but transient neurological deterioration revealing adult polyglucosan body disease. ( 23146612 )
2013
16
Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease. ( 23266647 )
2013
17
Childhood presentation of "adult" polyglucosan body disease: normal GBE1 sequence with no glycogen branching enzyme activity. ( 23526558 )
2013
18
Adult polyglucosan body disease masquerading as "ALS with dementia of the Alzheimer type": an exceptional phenotype in a rare pathology. ( 21572310 )
2012
19
The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background. ( 22943850 )
2012
20
Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings. ( 23034915 )
2012
21
Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions. ( 21538287 )
2011
22
Adult Polyglucosan Body Disease (APBD): Anaplerotic diet therapy (Triheptanoin) and demonstration of defective methylation pathways. ( 20655781 )
2010
23
Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene. ( 17994551 )
2008
24
Immunohistochemical and ultrastructural changes in the brain in probable adult glycogenosis type IV: adult polyglucosan body disease. ( 18825592 )
2008
25
Stable neuropsychological deficits in adult polyglucosan body disease. ( 16730990 )
2007
26
A case of adult polyglucosan body disease. ( 17722245 )
2007
27
Adult polyglucosan body disease: a case report of a manifesting heterozygote. ( 16007674 )
2005
28
Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome. ( 14755501 )
2004
29
Adult polyglucosan body disease associated with lewy bodies and tremor. ( 12756142 )
2003
30
Adult polyglucosan body disease: a postmortem correlation study. ( 12874416 )
2003
31
Adult polyglucosan body disease. ( 11260627 )
2001
32
Extensive white-matter changes in case of adult polyglucosan body disease. ( 11305757 )
2001
33
Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. ( 10762170 )
2000
34
Probable adult polyglucosan body disease. ( 11126844 )
2000
35
Adult polyglucosan body disease associated with an extrapyramidal syndrome. ( 9810960 )
1998
36
Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. ( 9851430 )
1998
37
Familial dementia due to adult polyglucosan body disease. ( 9266150 )
1997
38
Sevoflurane anaesthesia for a patient with adult polyglucosan body disease. ( 8955978 )
1996
39
Dementia of frontal lobe type due to adult polyglucosan body disease. ( 8530979 )
1995
40
Adult polyglucosan body disease. ( 7922101 )
1994
41
Dementia of adult polyglucosan body disease. Evidence of cortical and subcortical dysfunction. ( 8274116 )
1994
42
Glycogen branching enzyme deficiency in adult polyglucosan body disease. ( 8494336 )
1993
43
Spinal cord MRI in adult polyglucosan body disease. ( 1522280 )
1992
44
Adult polyglucosan body disease: the diagnostic value of axilla skin biopsy. ( 1656844 )
1991
45
Hereditary branching enzyme dysfunction in adult polyglucosan body disease: a possible metabolic cause in two patients. ( 1763891 )
1991
46
Adult polyglucosan body disease (APBD). ( 2838589 )
1988
47
Adult polyglucosan body disease: clinical and nerve biopsy findings in two cases. ( 6301360 )
1983
48
A type of adult polyglucosan body disease. ( 6814164 )
1982
49
A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora's disease and normal ageing. ( 6249438 )
1980

Variations for Polyglucosan Body Neuropathy, Adult Form

UniProtKB/Swiss-Prot genetic disease variations for Polyglucosan Body Neuropathy, Adult Form:

76
# Symbol AA change Variation ID SNP ID
1 GBE1 p.Arg515His VAR_022433 rs201958741
2 GBE1 p.Arg524Gln VAR_022434 rs80338673

ClinVar genetic disease variations for Polyglucosan Body Neuropathy, Adult Form:

6 (show top 50) (show all 76)
# Gene Variation Type Significance SNP ID Assembly Location
1 GBE1 NM_000158.3(GBE1): c.986A> C (p.Tyr329Ser) single nucleotide variant Pathogenic rs80338671 GRCh37 Chromosome 3, 81691938: 81691938
2 GBE1 NM_000158.3(GBE1): c.986A> C (p.Tyr329Ser) single nucleotide variant Pathogenic rs80338671 GRCh38 Chromosome 3, 81642787: 81642787
3 GBE1 NM_000158.3(GBE1): c.784C> T (p.Arg262Cys) single nucleotide variant Pathogenic rs137852893 GRCh37 Chromosome 3, 81692140: 81692140
4 GBE1 NM_000158.3(GBE1): c.784C> T (p.Arg262Cys) single nucleotide variant Pathogenic rs137852893 GRCh38 Chromosome 3, 81642989: 81642989
5 GBE1 NM_000158.3(GBE1): c.568A> G (p.Arg190Gly) single nucleotide variant Benign rs2229519 GRCh37 Chromosome 3, 81698130: 81698130
6 GBE1 NM_000158.3(GBE1): c.568A> G (p.Arg190Gly) single nucleotide variant Benign rs2229519 GRCh38 Chromosome 3, 81648979: 81648979
7 GBE1 NM_000158.3(GBE1): c.691+2T> C single nucleotide variant Pathogenic/Likely pathogenic rs192044702 GRCh37 Chromosome 3, 81698005: 81698005
8 GBE1 NM_000158.3(GBE1): c.691+2T> C single nucleotide variant Pathogenic/Likely pathogenic rs192044702 GRCh38 Chromosome 3, 81648854: 81648854
9 GBE1 NM_000158.3(GBE1): c.1716C> T (p.Asp572=) single nucleotide variant Benign/Likely benign rs2229520 GRCh37 Chromosome 3, 81586149: 81586149
10 GBE1 NM_000158.3(GBE1): c.1716C> T (p.Asp572=) single nucleotide variant Benign/Likely benign rs2229520 GRCh38 Chromosome 3, 81536998: 81536998
11 GBE1 NM_000158.3(GBE1): c.1519A> G (p.Thr507Ala) single nucleotide variant Benign/Likely benign rs2228389 GRCh37 Chromosome 3, 81627175: 81627175
12 GBE1 NM_000158.3(GBE1): c.1519A> G (p.Thr507Ala) single nucleotide variant Benign/Likely benign rs2228389 GRCh38 Chromosome 3, 81578024: 81578024
13 GBE1 NM_000158.3(GBE1): c.839G> A (p.Gly280Asp) single nucleotide variant Benign/Likely benign rs28763902 GRCh37 Chromosome 3, 81692085: 81692085
14 GBE1 NM_000158.3(GBE1): c.839G> A (p.Gly280Asp) single nucleotide variant Benign/Likely benign rs28763902 GRCh38 Chromosome 3, 81642934: 81642934
15 GBE1 NM_000158.3(GBE1): c.579G> A (p.Lys193=) single nucleotide variant Benign rs17019144 GRCh37 Chromosome 3, 81698119: 81698119
16 GBE1 NM_000158.3(GBE1): c.579G> A (p.Lys193=) single nucleotide variant Benign rs17019144 GRCh38 Chromosome 3, 81648968: 81648968
17 GBE1 NM_000158.3(GBE1): c.342C> T (p.Tyr114=) single nucleotide variant Benign rs13320194 GRCh37 Chromosome 3, 81720076: 81720076
18 GBE1 NM_000158.3(GBE1): c.342C> T (p.Tyr114=) single nucleotide variant Benign rs13320194 GRCh38 Chromosome 3, 81670925: 81670925
19 GBE1 NM_000158.3(GBE1): c.176T> C (p.Ile59Thr) single nucleotide variant Benign/Likely benign rs28763904 GRCh37 Chromosome 3, 81754732: 81754732
20 GBE1 NM_000158.3(GBE1): c.176T> C (p.Ile59Thr) single nucleotide variant Benign/Likely benign rs28763904 GRCh38 Chromosome 3, 81705581: 81705581
21 GBE1 NM_000158.3(GBE1): c.143+10G> T single nucleotide variant Benign/Likely benign rs9820490 GRCh37 Chromosome 3, 81810516: 81810516
22 GBE1 NM_000158.3(GBE1): c.143+10G> T single nucleotide variant Benign/Likely benign rs9820490 GRCh38 Chromosome 3, 81761365: 81761365
23 GBE1 NM_000158.3(GBE1): c.1581G> A (p.Thr527=) single nucleotide variant Uncertain significance rs140571802 GRCh38 Chromosome 3, 81577962: 81577962
24 GBE1 NM_000158.3(GBE1): c.1581G> A (p.Thr527=) single nucleotide variant Uncertain significance rs140571802 GRCh37 Chromosome 3, 81627113: 81627113
25 GBE1 NM_000158.3(GBE1): c.1406A> G (p.Tyr469Cys) single nucleotide variant Uncertain significance rs760661724 GRCh38 Chromosome 3, 81581205: 81581205
26 GBE1 NM_000158.3(GBE1): c.1406A> G (p.Tyr469Cys) single nucleotide variant Uncertain significance rs760661724 GRCh37 Chromosome 3, 81630356: 81630356
27 GBE1 NM_000158.3(GBE1): c.647A> G (p.Tyr216Cys) single nucleotide variant Uncertain significance rs886058901 GRCh38 Chromosome 3, 81648900: 81648900
28 GBE1 NM_000158.3(GBE1): c.647A> G (p.Tyr216Cys) single nucleotide variant Uncertain significance rs886058901 GRCh37 Chromosome 3, 81698051: 81698051
29 GBE1 NM_000158.3(GBE1): c.-102C> T single nucleotide variant Likely benign rs886058903 GRCh38 Chromosome 3, 81761618: 81761618
30 GBE1 NM_000158.3(GBE1): c.-102C> T single nucleotide variant Likely benign rs886058903 GRCh37 Chromosome 3, 81810769: 81810769
31 GBE1 NM_000158.3(GBE1): c.*558T> C single nucleotide variant Uncertain significance rs886058899 GRCh38 Chromosome 3, 81489849: 81489849
32 GBE1 NM_000158.3(GBE1): c.*558T> C single nucleotide variant Uncertain significance rs886058899 GRCh37 Chromosome 3, 81539000: 81539000
33 GBE1 NM_000158.3(GBE1): c.*466G> A single nucleotide variant Uncertain significance rs571158601 GRCh38 Chromosome 3, 81489941: 81489941
34 GBE1 NM_000158.3(GBE1): c.*466G> A single nucleotide variant Uncertain significance rs571158601 GRCh37 Chromosome 3, 81539092: 81539092
35 GBE1 NM_000158.3(GBE1): c.*176G> A single nucleotide variant Benign rs846 GRCh38 Chromosome 3, 81490231: 81490231
36 GBE1 NM_000158.3(GBE1): c.*176G> A single nucleotide variant Benign rs846 GRCh37 Chromosome 3, 81539382: 81539382
37 GBE1 NM_000158.3(GBE1): c.1874T> G (p.Phe625Cys) single nucleotide variant Uncertain significance rs769567764 GRCh38 Chromosome 3, 81535255: 81535255
38 GBE1 NM_000158.3(GBE1): c.1874T> G (p.Phe625Cys) single nucleotide variant Uncertain significance rs769567764 GRCh37 Chromosome 3, 81584406: 81584406
39 GBE1 NM_000158.3(GBE1): c.1392C> T (p.Leu464=) single nucleotide variant Uncertain significance rs563241317 GRCh38 Chromosome 3, 81581219: 81581219
40 GBE1 NM_000158.3(GBE1): c.1392C> T (p.Leu464=) single nucleotide variant Uncertain significance rs563241317 GRCh37 Chromosome 3, 81630370: 81630370
41 GBE1 NM_000158.3(GBE1): c.*395A> G single nucleotide variant Uncertain significance rs138608612 GRCh38 Chromosome 3, 81490012: 81490012
42 GBE1 NM_000158.3(GBE1): c.*395A> G single nucleotide variant Uncertain significance rs138608612 GRCh37 Chromosome 3, 81539163: 81539163
43 GBE1 NM_000158.3(GBE1): c.1803G> A (p.Gln601=) single nucleotide variant Uncertain significance rs368793136 GRCh38 Chromosome 3, 81536911: 81536911
44 GBE1 NM_000158.3(GBE1): c.1803G> A (p.Gln601=) single nucleotide variant Uncertain significance rs368793136 GRCh37 Chromosome 3, 81586062: 81586062
45 GBE1 NM_000158.3(GBE1): c.859G> C (p.Val287Leu) single nucleotide variant Uncertain significance rs116899644 GRCh38 Chromosome 3, 81642914: 81642914
46 GBE1 NM_000158.3(GBE1): c.859G> C (p.Val287Leu) single nucleotide variant Uncertain significance rs116899644 GRCh37 Chromosome 3, 81692065: 81692065
47 GBE1 NM_000158.3(GBE1): c.144-7T> C single nucleotide variant Uncertain significance rs886058902 GRCh38 Chromosome 3, 81705620: 81705620
48 GBE1 NM_000158.3(GBE1): c.144-7T> C single nucleotide variant Uncertain significance rs886058902 GRCh37 Chromosome 3, 81754771: 81754771
49 GBE1 NM_000158.3(GBE1): c.*598G> C single nucleotide variant Uncertain significance rs886058898 GRCh38 Chromosome 3, 81489809: 81489809
50 GBE1 NM_000158.3(GBE1): c.*598G> C single nucleotide variant Uncertain significance rs886058898 GRCh37 Chromosome 3, 81538960: 81538960

Expression for Polyglucosan Body Neuropathy, Adult Form

Search GEO for disease gene expression data for Polyglucosan Body Neuropathy, Adult Form.

Pathways for Polyglucosan Body Neuropathy, Adult Form

GO Terms for Polyglucosan Body Neuropathy, Adult Form

Sources for Polyglucosan Body Neuropathy, Adult Form

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....